by Kyle | Oct 12, 2021 | Press Release
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease (DED) diagnostics, today announced...
by Kyle | Oct 11, 2021 | Press Release
Dr. Perry is Third World-Class Ophthalmologist to Join the Advisory Board SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting...
by Kyle | Oct 5, 2021 | Press Release
Dr. Periman Joins Chairman Joseph Tauber as Advisory Board’s Second Member SAN DIEGO, Oct. 05, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting...
by Kyle | Sep 21, 2021 | Press Release
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” or “the Company”), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease (DED) diagnostics, today announced that...
by Kyle | Sep 15, 2021 | Press Release
Busby to Direct Dry Eye Disease Commercial Launch for Recently Acquired Diagnostic Tech SAN DIEGO — September 15, 2021 — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a leader in the development of diagnostic testing...
by Kyle | Aug 30, 2021 | Press Release
SAN DIEGO, Aug. 30, 2021 (GLOBE NEWSWIRE) — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological, COVID-19 and dry eye disease diagnostics, announced today that...
